Single and Double Emulsion Manufacturing Techniques of an Amphiphilic Drug in PLGA Nanoparticles: Formulations of Mithramycin and Bioactivity
Authors:
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 98 (4) , 1452-1462
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in ratsJournal of Controlled Release, 2007
- Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosisJournal of Controlled Release, 2006
- Inflammation and restenosis after percutaneous coronary interventionsEuropean Heart Journal, 2004
- Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation After Balloon Injury in Rats and RabbitsCirculation, 2002
- Preparation Techniques and Mechanisms of Formation of Biodegradable Nanoparticles from Preformed PolymersDrug Development and Industrial Pharmacy, 1998
- Formulation and characterization of biodegradable nanoparticles for intravascular local drug deliveryJournal of Controlled Release, 1997
- Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury modelAtherosclerosis, 1996
- Rapid Communication: Mithramycin Selectively Inhibits Transcription Of G-C Containing DNAThe American Journal of the Medical Sciences, 1987
- Preliminary Observations on the Therapy of the Myeloid Blast Phase of Chronic Granulocytic Leukemia with Plicamycin and HydroxyureaNew England Journal of Medicine, 1986
- Actions of calcitonin and mithramycinArthritis & Rheumatism, 1980